Back

Risk of post-transplant cyclophosphamide-related cardiotoxicity in allogeneic stem cell transplantation

19 June 2026 (11:45 - 12:45)
Organised by: Logo
Congress Presentation Part of: Stratifying the risk of cardiotoxicity (1) Stratification, Prevention and Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Trecy Goncalves

University Health Network of Toronto, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
Left atrioventricular coupling index: a novel predictor of cardiovascular adverse events during cardiotoxic therapy in multiple myeloma patients
Professor A. Milan (Turin, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of high-sensitivity Troponin I vs T in metastatic melanoma patients with immune checkpoint inhibitor-related low-risk myocarditis
Doctor V. Rossi (Zurich, CH)
Abstract Slides
Presentation thumbnail
External validation of models predicting heart failure in haematological malignancies
Doctor J. Geels (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Baseline lipoprotein(a) and heart failure-related events in oncology patients: competing-risk analysis
Assistant Professor A. Campos Staffico (Omaha, US)
Abstract Slides
Presentation thumbnail
Baseline cardiovascular and cardiotoxicity risk in newly diagnosed breast cancer: insights from a nationwide turkish registry (CARPE DIEM-TR)
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Stratifying the risk of cardiotoxicity (1)

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 11:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources